The average G1 Therapeutics stock price prediction forecasts a potential downside of NA from the current GTHX share price of 2226. G1 Therapeutics stock forecast analyst price target predictions based on 6 analysts offering 12-months price targets for GTHX in the last 3 months.
What Kind Of Shareholders Own G1 Therapeutics Inc Nasdaq Gthx
Sharpless on May 19 2008 and is headquartered in Research Triangle Park NC.
G1 therapeutics stock forecast. G1 Therapeutics Inc Stock Market info Recommendations. However solely looking at the historical price movement is usually misleading. 2366 G1 Therapeutics stock forecast for 24042021.
2300 Positive intraday dynamics of the instrument is expected with 4735 volatility is expected. Is G1 Therapeutics Inc. G1 Therapeutics Inc.
GTHX 2278 052 234. About the G1 Therapeutics Inc. Buy or sell G1 Therapeutics stock.
There are mixed signals in the stock today. G1 Therapeutics Inc has risen higher in 1 of those 3 years over the subsequent 52 week period corresponding to a. G1 Therapeutics Inc NASDAQ Updated Apr 27 2021 1047 AM.
3389 G1 Therapeutics stock forecast for Feb 2023. At the same time however the long-term average holds a general sell signal. Youll find the G1 Therapeutics share forecasts stock quote and buy sell signals belowAccording to present data G1 Therapeuticss GTHX shares and potentially its market environment have been in a bullish cycle in the last 12.
Advertentie 7283 of retail CFD accounts lose money. G1 Therapeutics stock forecast for Jan 2023. GTHX stock quote history news and other vital information to help you with your stock trading and investing.
18 rijen G1 Therapeutics Inc Stock Forecast NASDAQGTHX Price Target and Analyst Ratings. Estimated Average Forecasted G1 Therapeutics Price. G1 Therapeuticss share price could stay at 5700 by Feb 25 2022.
As of 2021 April 22 Thursday current price of GTHX stock is 23490 and our data indicates that the asset price has been in an uptrend for the past 1 year or since its inception. G1 Therapeutics stock forecast for 23042021. The company was founded by Kwok-Kin Wong and Norman E.
Its products pipeline includes trilaciclib rintodestrant and lerociclib. Find the latest G1 Therapeutics Inc. Engages in the development of small molecule therapeutics for the treatment of patients with cancer.
Advertentie 7283 of retail CFD accounts lose money. Positive monthly dynamics of the instrument is expected with 18166 volatility is expected. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock.
Find real-time GTHX - G1 Therapeutics Inc stock quotes company profile news and forecasts from CNN Business. The G1 Therapeutics Inc stock holds a buy signal from the short-term moving average. 3000 real stocks to invest in without commissions such as Delta Tesla and others.
3000 real stocks to invest in without commissions such as Delta Tesla and others. Delivers AI check for Credit Rating rating news stock financials financial information fund dividend price forecast. Investors can use this forecasting interface to forecast G1 Therapeutics historical stock prices and determine the direction of G1 Therapeuticss future trends based on various well-known forecasting models.
Estimated Average Forecasted G1 Therapeutics Price. Wall Street Stock Market Finance report prediction for the future. G1 Therapeutics stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame.
G1 Therapeutics Inc Stock Forecast Over the next 52 weeks G1 Therapeutics Inc has on average historically risen by 23 based on the past 3 years of. On average Wall Street analysts predict that.